Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-403-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01 - 23 August 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well conducted and well described study in accordance with GLP and OECD Guideline 429 without any deviation.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- ethanol water extract from husk of Chenopodium quinoa, Chenopodiaceae
- IUPAC Name:
- ethanol water extract from husk of Chenopodium quinoa, Chenopodiaceae
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material: MEXORYL SCK
- Physical state: Beige powder
- Analytical purity: saponines content (determined by HPLC assay) 57.0 % w/w
- Lot/batch No.: R0069579A 008 X 001
- Expiration date of the lot/batch: September 2012
- Storage condition of test material: At room temperature away from light
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Animal breeding facility, JRF.
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 18-23.5 g
- Housing: Animals were housed individually in solid floor polypropylene cages. On Day 5, post administration of the radiolabelled material, the animals were transferred to the metal metabolic cages.
- Diet: Teklad certified Global High Fiber Rat/Mice feed (manufactured by Harlan, Nederland), ad libitum
- Water: UV sterilised water (Reverse Osmosis water filtration system), ad libitum
- Acclimation period: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature: 19-22 °C
- Humidity: 64-65 %
- Photoperiod: 12 h dark / 12 h light
Study design: in vivo (LLNA)
- Vehicle:
- other: 1 % pluronic L-92
- Concentration:
- Preliminary study: 5, 10, 25 and 50 % (w/v) in 1 % pluronic L-92
Main study: 2.5, 5, 10, 25 and 50 % (w/v) in 1 % pluronic L-92 - No. of animals per dose:
- Preliminary study: 2 females/dose
Main study: 4 females/dose - Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: Test item was found to be soluble in 1 % pluronic L-92 and homogenous solution was obtained up to the maximum concentration of 50 % (w/v)
- Irritation: No sign of toxicity at the concentrations of 5, 10, 25 and 50 % (w/v). There was no noteworthy increase observed in ear thickness measurement. Therefore, the concentrations selected for the main study were 2.5, 5, 10, 25 and 50 % (w/v).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Individual approach, using tritiated (3H)-methyl thymidine, according to the OECD 429 test guideline.
- Additional investigation: Measurement of ear thickness - Ear thickness of individual animal was measured using a digital micrometer on the day of the commencement (Day 0) and on Days 1, 2 and 5, altogether with recording of local reactions if any before each application. Group mean ear thickness was calculated.
- Criteria used to consider a positive response: Test item was regarded as skin sensitizer when the Stimulation Index (SI) for a dose group is ≥ 3 together with consideration of a dose-response relationship.
TREATMENT PREPARATION AND ADMINISTRATION:
- Fresh dose solutions were prepared every day prior to application. Test item dosage forms were used within 1 hour after preparation.
- 25 µL of test material was applied to the dorsum surface of each ear of each mouse for three consecutive days (Days 0, 1 and 2). On day 5 an injection of 250 µL phosphate buffered saline (PBS) containing 20 µCi of 3H-methyl thymidine (3H-TdR) or 250 µl PBS containing 2 µCi of (3H)-methyl thymidine was made into the tail vein of each experimental mouse. Five hours later, the draining Auricular lymph node of each ear was excised into PBS. A single cell suspension of lymph node cells was prepared from each mouse. Cells were precipitated with 5% trichloroacetic acid at 4 ± 1 °C for 18 hours. Then precipitate was transferred to a scintillation vials with 10 mL scintillation fluid, vials were loaded into a β- scintillation counter and after approximately 30 minutes 3H-TdR incorporation was measured as disintegrations per minute (DPM) for each group and expressed DPM/group and DPM/node. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical analysis was carried for the assessment of the dose response relationship and pair wise comparison between the treatment and vehicle control group. The body weight data was subjected to Bartlett's test to meet the homogeneity of variance before conducting ANOVA followed by Dunnett's t test. Where the data do not meet the homogeneity of variance Student's t test was performed to calculate significance.
Results and discussion
- Positive control results:
- Stimulation index for positive control group treated with 25 % (v/v) hexyl cinnamic aldehyde was found to be 3.77 and classified as skin sensitizer.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: Stimulation index for 2.5, 5, 10, 25 and 50 % (w/v) were 1.33, 1.78, 2.02, 2.13 and 3.54, respectively. EC3 value calculated for the test item was found to be 40.43 %.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: DPM/group for vehicle, 2.5, 5, 10, 25 and 50 % (w/v) were 2477.87, 3290.39, 4402.91, 5006.32, 5289.28 and 8782.63, respectively.
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the test conditions, test item, MEXORYL SCK is classified as a skin sensitiser according to the annex VI of the Regulation EC No. 1272/2008 (CLP) and of the Directive 67/548/EEC.
- Executive summary:
- In
a local lymph node assay performed according to OECD Guideline 429 and in
compliance with GLP, groups of CBA/J mice (4 females/dose) were treated
with test item, MEXORYL SCK at concentrations of 2.5, 5, 10, 25 and 50 %
(w/v) in 1 % pluronic L-92 to the dorsum of ears (25 µL/ear) on three
consecutive days. Four vehicle control animals were treated with vehicle
alone (1 % pluronic L-92) and four positive controls were treated with
Hexylcinnamaldehyde (25 %). Three days after the last exposure, all
animals were injected with 3H–methyl thymidine and after five
hours the draining (auricular) lymph nodes were excised. After
precipitating the DNA of the lymph node cells, radioactivity measurements
were performed. The activity was expressed as the number of
Disintegrations Per Minute (DPM) and a stimulation index (SI) was
subsequently calculated for each group. Animals were observed for
mortality, clinical signs and body weight during the study. The test
concentrations for the main study were determined from a preliminary
irritation study at 5, 10, 25 and 50 % (w/v) in 1 % pluronic L-92 using
two females/dose.
No mortality and no clinical signs were observed during the observation period. Mean body weights of treatment group animals was comparable to that of the vehicle control. There was no noteworthy increase observed in ear thickness measurement on Days 0, 1, 2 and 5 in all groups. DPM/group for vehicle, 2.5, 5, 10, 25 and 50 % (w/v) were 2477.87, 3290.39, 4402.91, 5006.32, 5289.28 and 8782.63, respectively. Stimulation index for 2.5, 5, 10, 25 and 50 % (w/v) were 1.33, 1.78, 2.02, 2.13 and 3.54, respectively. EC3 value calculated for the test item was found to be 40.43 %. Stimulation index for positive control group treated with 25 % (v/v) hexyl cinnamic aldehyde was found to be 3.77 and classified as skin sensitizer; this experiment was therefore considered valid. Since Stimulation index obtained for 50 % (w/v) tested dose concentrations of test item revealed three-fold increase over the vehicle control, associated with dose-response relationship, the test item may be categorized as a weak sensitizer.
Under the test conditions, test item, MEXORYL SCK is classified as a skin sensitiser according to the annex VI of the Regulation EC No. 1272/2008 (CLP) and of the Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.